AbFero Pharmaceuticals, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 2016-01-01
- Employees
- 11
- Market Cap
- -
SP-420 in Subjects With Transfusion-dependent Beta-Thalassemia or Other Rare Anemias
- First Posted Date
- 2019-01-14
- Last Posted Date
- 2020-10-05
- Lead Sponsor
- Abfero Pharmaceuticals, Inc
- Registration Number
- NCT03801889
- Locations
- 🇨🇦
University of Toronto- University Health Network, Toronto, Canada
🇱🇧American University of Beirut Medical Center, Beirut, Lebanon
🇹🇷Ege University Hospital, İzmir, Turkey
© Copyright 2025. All Rights Reserved by MedPath